<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="crh9718800" xml:lang="en" article-type="case-study" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Case Rep Hematol</journal-id><journal-id journal-id-type="iso-abbrev">Case Rep Hematol</journal-id><journal-id journal-id-type="pmc-domain-id">1876</journal-id><journal-id journal-id-type="pmc-domain">crimhematology</journal-id><journal-id journal-id-type="publisher-id">CRH</journal-id><journal-title-group><journal-title>Case Reports in Hematology</journal-title></journal-title-group><issn pub-type="ppub">2090-6560</issn><issn pub-type="epub">2090-6579</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12746173</article-id><article-id pub-id-type="pmcid-ver">PMC12746173.1</article-id><article-id pub-id-type="pmcaid">12746173</article-id><article-id pub-id-type="pmcaiid">12746173</article-id><article-id pub-id-type="pmid">41473418</article-id><article-id pub-id-type="doi">10.1155/crh/9718800</article-id><article-id pub-id-type="publisher-id">CRH9718800</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Caught by Whole&#8208;Exome Sequencing: Hemoglobin Sun Prairie in a Patient With Unexplained Hemolytic Anemia From Nepal</article-title></title-group><contrib-group><contrib id="cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Upadhaya</surname><given-names initials="P">Prashun</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8253-648X</contrib-id><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>prashun889@gmail.com</email></address></contrib><contrib id="cr-0002" contrib-type="author"><name name-style="western"><surname>Shrestha</surname><given-names initials="A">Anjan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2205-0354</contrib-id><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><contrib-group><contrib id="cr-0003" contrib-type="editor"><name name-style="western"><surname>Antun</surname><given-names initials="A">Ana</given-names></name><address><email>ana.antun@emoryhealthcare.org</email></address></contrib></contrib-group><aff id="aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>, <named-content content-type="organisation-division">Hemato-Oncology Unit</named-content>, <named-content content-type="organisation-division">Maharajgunj Medical Campus</named-content>, <named-content content-type="organisation-division">Institute of Medicine</named-content>, <institution>Tribhuvan University Teaching Hospital</institution>, <city>Kathmandu</city>, <country>Nepal</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://teachinghospital.org.np" ext-link-type="uri">teachinghospital.org.np</ext-link>
</aff><pub-date pub-type="epub"><day>29</day><month>12</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>2025</volume><issue-id pub-id-type="pmc-issue-id">489174</issue-id><elocation-id>9718800</elocation-id><history><date date-type="rev-recd"><day>15</day><month>11</month><year>2025</year></date><date date-type="received"><day>20</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>12</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>12</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>30</day><month>12</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-12-31 09:25:14.720"><day>31</day><month>12</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">Copyright &#169; 2025 Prashun Upadhaya and Anjan Shrestha. Case Reports in Hematology published by John Wiley &amp; Sons Ltd.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CRH-2025-9718800.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CRH-2025-9718800.pdf"/><abstract><sec id="sec-0001"><title>Background</title><p>Unstable hemoglobin leading to chronic hemolysis is a rare yet an important cause of hemolytic anemia and can be easily missed if not thought of during evaluation. Hemoglobin Sun Prairie is an extremely rare &#945;&#8208;globin mutation associated with hemolytic anemia.</p></sec><sec id="sec-0002"><title>Case</title><p>We report a 22&#8208;year&#8208;old female from Nepal who presented with easy fatigability and jaundice since her childhood with worsening of symptoms for 2&#8201;months. Examination revealed pallor, icterus, and splenomegaly. Investigation showed anemia with low mean cell volume (MCV), reticulocytosis, indirect hyperbilirubinemia, and raised lactate dehydrogenase (LDH) level. Workup for etiology of hemolysis, including autoimmune, nutritional, RBC enzyme deficiency, and osmotic fragility, was negative. Hemoglobin electrophoresis was inconclusive. Whole&#8208;exome sequencing identified a pathogenic mutation in HBA2 gene, confirming Hemoglobin Sun Prairie. To our knowledge, this represents the first reported case of Hemoglobin Sun Prairie from Nepal.</p></sec><sec id="sec-0003"><title>Conclusion</title><p>This case highlights the importance of genetic testing in an unexplained hemolytic anemia. Genetic testing such as whole&#8208;exome sequencing would help in the early identification of rare causes of hemolytic anemia which can guide in the genetic counseling and prevent unnecessary investigations and interventions.</p></sec></abstract><kwd-group><title>Keywords</title><kwd id="kwd-0001">hemoglobinopathy</kwd><kwd id="kwd-0002">Hemoglobin Sun Prairie</kwd><kwd id="kwd-0003">hemolytic anemia</kwd><kwd id="kwd-0004">Nepal</kwd><kwd id="kwd-0005">unstable hemoglobin</kwd><kwd id="kwd-0006">whole-exome sequencing</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><ref-count count="11"/><page-count count="5"/><word-count count="1503"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.6 mode:remove_FC converted:29.12.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="crh9718800-cit-2001"><string-name name-style="western"><surname>Upadhaya</surname>, <given-names>Prashun</given-names></string-name>, 
<string-name name-style="western"><surname>Shrestha</surname>, <given-names>Anjan</given-names></string-name>, 
<article-title>Caught by Whole&#8208;Exome Sequencing: Hemoglobin Sun Prairie in a Patient With Unexplained Hemolytic Anemia From Nepal</article-title>, 
<source>Case Reports in Hematology</source>, <volume>2025</volume>, <elocation-id>9718800</elocation-id>, 5 pages, <year>2025</year>. 
<pub-id pub-id-type="doi">10.1155/crh/9718800</pub-id></mixed-citation>
</p><fn-group><fn id="note-0001"><p>
<bold>Academic Editor:</bold> Ana Antun</p></fn></fn-group></notes></front><body><sec id="sec-0004"><title>1. Introduction</title><p>Hemoglobinopathies are the most common monogenic disease worldwide, caused by structural abnormalities or quantitative defects in the globin chains of hemoglobin, and include the common structural disorders such as sickle cell disease and the thalassemias [<xref rid="bib-0001" ref-type="bibr">1</xref>]. The clinical spectrum of hemoglobinopathies ranges from an asymptomatic carrier state to life&#8208;threatening anemia. In a clinically suspected case, diagnostic evaluations include complete blood count (CBC) with peripheral blood smear that show clues such as microcytic anemia, normal to high RBC count and RDW, microcytosis, target cells, anisopoikilocytosis, sickle cells, basophilic stippling, and nucleated RBCs [<xref rid="bib-0002" ref-type="bibr">2</xref>]. High&#8208;performance liquid chromatography (HPLC) or capillary electrophoresis (CE) helps to characterize the hemoglobin, whereas targeted mutation analysis or sequencing identifies the specific globin gene mutation [<xref rid="bib-0003" ref-type="bibr">3</xref>]. Targeted laboratory series, hospital registries, and regional field surveys in Nepal show that thalassemias are unevenly distributed across the country, with higher frequencies among some ethnic groups and southern plains, and pose a significant public health burden [<xref rid="bib-0004" ref-type="bibr">4</xref>&#8211;<xref rid="bib-0006" ref-type="bibr">6</xref>].</p></sec><sec id="sec-0005"><title>2. Case Presentation</title><p>A 22&#8208;year&#8208;old female from eastern Nepal presented to our hematology clinic with complaints of generalized fatigue and intermittent yellowish discoloration of eyes since childhood which had increased for 2&#8201;months. She had been transfused with 3 units of packed red blood cell at the age of 12&#8201;years for anemia. There was no history of joint pain, rashes, photosensitivity, dark&#8208;colored urine, or gall stone disease. She was born of a nonconsanguineous marriage, and her family history was unremarkable with no known cases of anemia, jaundice, blood disorders, or transfusion requirements.</p><p>On examination, the patient was pale and icteric with splenomegaly of 4&#8201;cm below the left subcostal margin. There was no lymphadenopathy or hepatomegaly. Cardiovascular and respiratory system examinations were otherwise normal.</p><p>Initial laboratory workup showed a hemoglobin level of 5.8&#8201;g/dL and an absolute reticulocyte count of 352,000/cu mm, with normal WBC and platelet counts. Peripheral blood smear revealed anisopoikilocytosis with polychromasia, tear&#8208;drop cells, target cells, and few fragmented cells. Serum biochemistry revealed elevated LDH (694&#8201;U/L) and indirect hyperbilirubinemia (bilirubin total 110&#8201;&#956;mol/L and bilirubin direct 17&#8201;&#956;mol/L), with a normal iron profile. Initial investigations are shown in Table <xref rid="tbl-0001" ref-type="table">1</xref>. A review of available prior records and serial laboratory results showed values similar to that at the presentation.</p><table-wrap position="float" id="tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Laboratory test parameters at presentation.</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><tbody><tr><td align="left" rowspan="1" colspan="1">Hemoglobin</td><td align="center" rowspan="1" colspan="1">5.8&#8201;g/dL</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC</td><td align="center" rowspan="1" colspan="1">5000/cu mm</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet</td><td align="center" rowspan="1" colspan="1">242,000/cu mm</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean corpuscular volume (MCV)</td><td align="center" rowspan="1" colspan="1">76&#8201;fL</td></tr><tr><td align="left" rowspan="1" colspan="1">RBC count</td><td align="center" rowspan="1" colspan="1">2.57 million/cu mm</td></tr><tr><td align="left" rowspan="1" colspan="1">Absolute reticulocyte count</td><td align="center" rowspan="1" colspan="1">352,000/cu mm</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral blood smear</td><td align="center" rowspan="1" colspan="1">Anisopoikilocytosis, microcytic hypochromic RBCs with polychromasia, tear&#8208;drop cells, target cells, and few fragmented RBCs</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum LDH</td><td align="center" rowspan="1" colspan="1">694&#8201;U/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Bilirubin total</td><td align="center" rowspan="1" colspan="1">110&#8201;&#956;mol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Bilirubin direct</td><td align="center" rowspan="1" colspan="1">17&#8201;&#956;mol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum iron</td><td align="center" rowspan="1" colspan="1">110&#8201;&#956;g/dL</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum total iron binding capacity (TIBC)</td><td align="center" rowspan="1" colspan="1">203&#8201;&#956;g/dL</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum ferritin</td><td align="center" rowspan="1" colspan="1">70.2&#8201;ng/mL</td></tr><tr><td align="left" rowspan="1" colspan="1">Antineutrophilic antibody (ANA)</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Direct Coombs test</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose&#8208;6&#8208;phosphate dehydrogenase (G6PD) level</td><td align="center" rowspan="1" colspan="1">18.66&#8201;U/g</td></tr></tbody></table></table-wrap><p>The direct Coombs test was negative, and the G6PD level was normal. Capillary hemoglobin electrophoresis demonstrated a predominant HbA fraction of 95.6% (reference range: 96.8%&#8211;97.8%), a small additional fraction of 2.5% migrating in the HbF/variant window (reference range &#8804; 0.5%), and an HbA2 fraction of 1.9% (reference range: 2.2%&#8211;3.2%) (Figure <xref rid="fig-0001" ref-type="fig">1</xref>). The presence of a minor abnormal peak in the HbF/variant zone, in the context of ongoing hemolytic anemia and absence of &#946;&#8208;thalassemic indices, was suggestive of an unstable hemoglobin variant. To further delineate the etiology, whole&#8208;exome sequencing (WES) was performed externally using the Illumina NovaSeq 6000 platform and analyzed with the DRAGEN pipeline for alignment (GRCh38), variant calling, and annotation, which identified a homozygous c.391G&#8201;&gt;&#8201;C (p.Ala131Pro) mutation in the <italic toggle="yes">HBA2</italic> gene, consistent with Hb Sun Prairie, a rare &#945;&#8208;globin chain variant classified as &#8220;likely pathogenic&#8221; (Table <xref rid="tbl-0002" ref-type="table">2</xref>). Additionally, a heterozygous c.2555C&#8201;&gt;&#8201;T (p.Thr852Met) variant in the <italic toggle="yes">SPTB</italic> gene was detected and classified as a variant of uncertain significance. The combined findings confirmed the diagnosis of Hb Sun Prairie&#8211;associated hemolytic anemia. Family members were not available for genetic testing to confirm segregation of the mutation.</p><fig position="float" fig-type="Figure" id="fig-0001" orientation="portrait"><label>Figure 1</label><caption><p>Capillary hemoglobin electrophoresis showing HbA 95.6%, Hb variant in the HbF/variant window 2.5%, and HbA2 1.9%.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CRH-2025-9718800-g001.jpg"/></fig><table-wrap position="float" id="tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Whole&#8208;exome sequencing showing HBA2 mutation (Hb Sun Prairie) and additional SPTB variant<sup>&#8727;</sup>.</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">Gene and transcript</th><th align="center" rowspan="1" colspan="1">Location</th><th align="center" rowspan="1" colspan="1">Variant</th><th align="center" rowspan="1" colspan="1">Zygosity/inheritance</th><th align="center" rowspan="1" colspan="1">OMIM phenotype</th><th align="center" rowspan="1" colspan="1">Clinical significance</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>HBA2 (+)</p></list-item><list-item><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NM_000517.6">NM_000517.6</ext-link></p></list-item></list>
</td><td align="center" rowspan="1" colspan="1">Exon 3</td><td align="center" rowspan="1" colspan="1">c.391G&#8201;&gt;&#8201;C (p.Ala131Pro)</td><td align="center" rowspan="1" colspan="1">Homozygous/autosomal recessive</td><td align="center" rowspan="1" colspan="1">Hb Sun Prairie</td><td align="center" rowspan="1" colspan="1">Likely pathogenic (PM2, PS4, PS3, PP5)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>SPTB (&#8722;)</p></list-item><list-item><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NM_001355436.2">NM_001355436.2</ext-link></p></list-item></list>
</td><td align="center" rowspan="1" colspan="1">Exon 14</td><td align="center" rowspan="1" colspan="1">c.2555C&#8201;&gt;&#8201;T (p.Thr852Met)</td><td align="center" rowspan="1" colspan="1">Heterozygous/autosomal dominant/autosomal recessive</td><td align="center" rowspan="1" colspan="1">Anemia, neonatal hemolytic, fatal, or near&#8208;fatal/Elliptocytosis 3/Spherocytosis, Type 2</td><td align="center" rowspan="1" colspan="1">Uncertain significance<sup>#</sup> (PM2)</td></tr></tbody></table><table-wrap-foot><fn id="note-0002"><p>
<sup>&#8727;</sup>Genetic test results are reported based on the recommendations of the American College of Medical Genetics.</p></fn><fn id="note-0003"><p>
<sup>#</sup>Due to the lack of clinical evidence for this variant, it is classified as a variant of uncertain significance.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec-0006"><title>3. Discussion</title><p>Hemoglobin Sun Prairie is a type of alpha chain variant that results due to G&#8201;&#10230;&#8201;C mutation in Codon 130 of &#945;2 gene resulting in replacement of alanine residue by a proline residue in the H helix. The resulting &#945; chain is unstable and precipitates within the red cell, causing hemolysis. Other manifestations include reticulocytosis, indirect hyperbilirubinemia, and splenomegaly all of which were present in our patient [<xref rid="bib-0007" ref-type="bibr">7</xref>]. It has a recessive pattern of inheritance with heterozygous individual demonstrating asymptomatic thalassemia carrier phenotype, while homozygous state leads to chronic hemolytic anemia [<xref rid="bib-0008" ref-type="bibr">8</xref>]. After its first description in a young patient of Indian origin with severe hemolytic anemia, only a handful of patients have been further reported worldwide [<xref rid="bib-0007" ref-type="bibr">7</xref>, <xref rid="bib-0009" ref-type="bibr">9</xref>&#8211;<xref rid="bib-0011" ref-type="bibr">11</xref>].</p><p>Conventional techniques such as HPLC or hemoglobin electrophoresis often fail to detect this variant, posing a diagnostic challenge [<xref rid="bib-0007" ref-type="bibr">7</xref>]. Hence, molecular techniques, such as DNA sequencing, are often required. In resource&#8208;limited settings like ours, diagnosis of hemoglobin variants relies on hemoglobin electrophoresis and HPLC. However, these methods may fail to clearly distinguish rare variants, especially when the abnormal peak is small or overlaps with HbF or HbA2. In Hb Sun Prairie, homozygous state of the pathogenic mutation leads to an abnormal peak and low HbA2 percentage [<xref rid="bib-0010" ref-type="bibr">10</xref>]. In our case, CE demonstrated a small peak at the HbF region (2.5%) and a slightly reduced HbA2 level (1.9%), which prompted further evaluation. WES confirmed the pathogenic <italic toggle="yes">HBA2</italic> mutation consistent with Hb Sun Prairie, highlighting the importance of molecular diagnostics in suspected rare hemoglobinopathies.</p><p>Interestingly, our patient also harbored a heterozygous <italic toggle="yes">SPTB</italic> gene variant (c.2555C&#8201;&gt;&#8201;T; p.Thr852Met), which is associated with hereditary spherocytosis and elliptocytosis, though its clinical significance in this case remains uncertain. While dual genetic findings can potentially contribute to phenotype severity, further functional studies are required to establish a causal relationship.</p><p>Unfortunately, family studies could not be performed, which would have strengthened the causal association of the identified variant. Though the patient is of Nepali origin, information on detailed ancestry and extended heritage could not be ascertained. Given Nepal&#8217;s proximity to Northern India where several hemoglobinopathy variants are prevalent, heritage data would have strengthened deeper epidemiologic interpretation.</p><p>To our knowledge, this is the first documented case of Hb Sun Prairie from Nepal, expanding the geographical spectrum of this rare hemoglobinopathy. Reporting such cases is crucial for raising awareness, guiding genetic counseling, and strengthening the role of advanced molecular testing in hematology practice.</p></sec><sec id="sec-0007"><title>4. Conclusion</title><p>We report the first case of Hb Sun Prairie&#8211;associated hemolytic anemia from Nepal, confirmed by hemoglobin electrophoresis and WES. This case highlights the importance of considering rare hemoglobin variants in the differential diagnosis of unexplained hemolytic anemia and underscores the role of molecular diagnostics in establishing a definitive diagnosis. Family studies, though not available in this instance, would further support genotype&#8211;phenotype correlation. Early recognition of such variants is essential for appropriate patient management and genetic counseling.</p></sec><sec id="sec-0010"><title>Ethics Statement</title><p>This case report does not need any ethical approval.</p></sec><sec id="sec-0011"><title>Consent</title><p>Written informed consent was obtained from the patient for publication of this case report.</p></sec><sec id="sec-0012"><title>Disclosure</title><p>The authors have no affiliations with or involvement in any organization or entity with any financial interests in the subject matter or materials discussed in the manuscript.</p></sec><sec sec-type="COI-statement" id="sec-0013"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="sec-0014"><title>Author Contributions</title><p>Prashun Upadhaya: conceptualization, data curation, and writing&#8211;original draft.</p><p>Anjan Shrestha: review and editing.</p></sec><sec id="sec-0015"><title>Funding</title><p>No funding was received for this manuscript.</p></sec></body><back><sec sec-type="data-availability" id="sec-0009"><title>Data Availability Statement</title><p>All relevant data supporting the findings of this case report are included within the article.</p></sec><ref-list><ref id="bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cit-0001"><string-name name-style="western"><surname>Harteveld</surname><given-names>C. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Achour</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Arkesteijn</surname><given-names>S. J. G.</given-names></string-name> et al., <article-title>The Hemoglobinopathies, Molecular Disease Mechanisms and Diagnostics</article-title>, <source>International Journal of Laboratory Hematology</source>. (<year>2022</year>) <volume>44</volume>, no. S1, <fpage>28</fpage>&#8211;<lpage>36</lpage>, <pub-id pub-id-type="doi">10.1111/ijlh.13885</pub-id>.<pub-id pub-id-type="pmid">36074711</pub-id><pub-id pub-id-type="pmcid">PMC9542123</pub-id></mixed-citation></ref><ref id="bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cit-0002"><string-name name-style="western"><surname>Bain</surname><given-names>B. J.</given-names></string-name>, <article-title>Haemoglobinopathy Diagnosis: Algorithms, Lessons and Pitfalls</article-title>, <source>Blood Reviews [Internet]</source>. (<year>2011</year>) <volume>25</volume>, no. 5, <fpage>205</fpage>&#8211;<lpage>213</lpage>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencedirect.com/science/article/pii/S0268960X11000336" ext-link-type="uri">https://www.sciencedirect.com/science/article/pii/S0268960X11000336</ext-link>, <pub-id pub-id-type="doi">10.1016/j.blre.2011.04.001</pub-id>, 2-s2.0-80051664429.<pub-id pub-id-type="pmid">21596464</pub-id></mixed-citation></ref><ref id="bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cit-0003"><string-name name-style="western"><surname>Salvatici</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Caslini</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Alesci</surname><given-names>S.</given-names></string-name> et al., <article-title>The Application of Clinical and Molecular Diagnostic Techniques to Identify a Rare Haemoglobin Variant</article-title>, <source>International Journal of Molecular Sciences</source>. (<year>2024</year>) <volume>25</volume>, no. 12, <pub-id pub-id-type="doi">10.3390/ijms25126781</pub-id>.<pub-id pub-id-type="pmcid">PMC11204072</pub-id><pub-id pub-id-type="pmid">38928486</pub-id></mixed-citation></ref><ref id="bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cit-0004"><string-name name-style="western"><surname>Sharma</surname><given-names>P. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Devkota</surname><given-names>A.</given-names></string-name>, and 
<string-name name-style="western"><surname>Kouides</surname><given-names>P.</given-names></string-name>, <article-title>Thalassemia Care in Nepal: In Dire Need of Improvement</article-title>, <source>eJHaem</source>. (May <year>2023</year>) <volume>4</volume>, no. 2, <fpage>548</fpage>&#8211;<lpage>550</lpage>, <pub-id pub-id-type="doi">10.1002/jha2.681</pub-id>.<pub-id pub-id-type="pmid">37206294</pub-id><pub-id pub-id-type="pmcid">PMC10188498</pub-id></mixed-citation></ref><ref id="bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cit-0005"><string-name name-style="western"><surname>Lama</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Yusof</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>Shrestha</surname><given-names>T. R.</given-names></string-name> et al., <article-title>Prevalence and Distribution of Major &#946;-Thalassemia Mutations and HbE/&#946;-Thalassemia Variant in Nepalese Ethnic Groups</article-title>, <source>Hematology/Oncology and Stem Cell Therapy</source>. (March <year>2022</year>) <volume>15</volume>, no. 1, <fpage>279</fpage>&#8211;<lpage>284</lpage>, <pub-id pub-id-type="doi">10.1016/j.hemonc.2021.01.004</pub-id>.<pub-id pub-id-type="pmid">33592169</pub-id></mixed-citation></ref><ref id="bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cit-0006"><string-name name-style="western"><surname>Shrestha</surname><given-names>R. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Pandit</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Yadav</surname><given-names>U. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Das</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Yadav</surname><given-names>B. K.</given-names></string-name>, and 
<string-name name-style="western"><surname>Upreti</surname><given-names>H. C.</given-names></string-name>, <article-title>Distribution of Hemoglobinopathy in Nepalese Population</article-title>, <source>Journal of Nepal Health Research Council</source>. (April <year>2020</year>) <volume>18</volume>, no. 1, <fpage>52</fpage>&#8211;<lpage>58</lpage>, <pub-id pub-id-type="doi">10.33314/jnhrc.v18i1.2303</pub-id>.<pub-id pub-id-type="pmid">32335593</pub-id></mixed-citation></ref><ref id="bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cit-0007"><string-name name-style="western"><surname>Harkness</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Harkness</surname><given-names>D. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Kutlar</surname><given-names>F.</given-names></string-name> et al., <article-title>Hb Sun Prairie or Alpha (2)130(H13)Ala----Pro Beta 2, a New Unstable Variant Occurring in Low Quantities</article-title>, <source>Hemoglobin</source>. (<year>1990</year>) <volume>14</volume>, no. 5, <fpage>479</fpage>&#8211;<lpage>489</lpage>, <pub-id pub-id-type="doi">10.3109/03630269009005801</pub-id>, 2-s2.0-0025609490.<pub-id pub-id-type="pmid">2079430</pub-id></mixed-citation></ref><ref id="bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cit-0008"><string-name name-style="western"><surname>Ho</surname><given-names>P. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Rochette</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Rees</surname><given-names>D. C.</given-names></string-name> et al., <article-title>Hb Sun Prairie: Diagnostic Pitfalls in Thalassemic Hemoglobinopathies</article-title>, <source>Hemoglobin [Internet]</source>. (January <year>1996</year>) <volume>20</volume>, no. 2, <fpage>103</fpage>&#8211;<lpage>112</lpage>, <pub-id pub-id-type="doi">10.3109/03630269609027915</pub-id>, 2-s2.0-0029747126.<pub-id pub-id-type="pmid">8811313</pub-id></mixed-citation></ref><ref id="bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cit-0009"><string-name name-style="western"><surname>Jain</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Prasad</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Chaudhry</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Gupta</surname><given-names>D. K.</given-names></string-name>, and 
<string-name name-style="western"><surname>Saluja</surname><given-names>S.</given-names></string-name>, <article-title>Hb Sun Prairie: A Rare Cause of Chronic Hemolysis in an Indian Patient</article-title>, <source>Hematol Oncol Stem Cell Ther [Internet]</source>. (<year>2021</year>) <volume>14</volume>, no. 3, <fpage>257</fpage>&#8211;<lpage>259</lpage>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencedirect.com/science/article/pii/S1658387620300303" ext-link-type="uri">https://www.sciencedirect.com/science/article/pii/S1658387620300303</ext-link>, <pub-id pub-id-type="doi">10.1016/j.hemonc.2019.11.002</pub-id>.<pub-id pub-id-type="pmid">32199931</pub-id></mixed-citation></ref><ref id="bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cit-0010"><string-name name-style="western"><surname>Nair</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Nadkarni</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Warang</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Bhave</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Ghosh</surname><given-names>K.</given-names></string-name>, and 
<string-name name-style="western"><surname>Colah</surname><given-names>R.</given-names></string-name>, <article-title>Five &#945; Globin Chain Variants Identified During Screening for Haemoglobinopathies</article-title>, <source>Eur J Clin Invest [Internet]</source>. (March <year>2010</year>) <volume>40</volume>, no. 3, <fpage>226</fpage>&#8211;<lpage>232</lpage>, <pub-id pub-id-type="doi">10.1111/j.1365-2362.2009.02252.x</pub-id>, 2-s2.0-77649221786.<pub-id pub-id-type="pmid">20100235</pub-id></mixed-citation></ref><ref id="bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cit-0011"><string-name name-style="western"><surname>Guida</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Colosimo</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Fichera</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Lombardo</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Rigoli</surname><given-names>L.</given-names></string-name>, and 
<string-name name-style="western"><surname>Dallapiccola</surname><given-names>B.</given-names></string-name>, <article-title>Hematologic and Molecular Characterization of a Sicilian Cohort of Alpha Thalassemia Carriers</article-title>, <source>Haematologica</source>. (March <year>2006</year>) <volume>91</volume>, no. 3, <fpage>409</fpage>&#8211;<lpage>410</lpage>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://haematologica.org/article/view/3898" ext-link-type="uri">https://haematologica.org/article/view/3898</ext-link>.<pub-id pub-id-type="pmid">16503552</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>